The present invention relates generally to massage devices and more particularly to a percussive therapy device that includes an electrically connected or smart attachment.
Massage devices often provide ineffective massages that are superficial and do not provide any real benefit. Accordingly, there is a need for an improved massage device. Furthermore, percussive massage devices are often used in an ineffective manner. Accordingly, there is a need for a percussive therapy device to be automated to provide effective massage or recovery.
In accordance with a first aspect of the present invention there is provided a percussive therapy system that includes a percussive therapy device that includes a housing, an electrical source, a motor positioned in the housing, a switch for activating the motor, a push rod assembly operatively connected to the motor and configured to reciprocate in response to activation of the motor, and an attachment configured to be operatively connected to a distal end of the push rod assembly of the percussive massage device and to provide at least one therapeutic effect to a user.
In a preferred embodiment, the attachment comprises at least one of an actuator configured to provide the at least one therapeutic effect to the user and a sensor configured to obtain at least one of biometric data of the user and information regarding operation of the percussive therapy device. The actuator may include at least one of a vibration actuator, a heating actuator, a cooling actuator, and an exfoliating actuator. The sensor may include at least one of a thermal sensor, an oxygen sensor, a blood flow sensor, a force meter, a gyroscope, and an accelerometer.
In a preferred embodiment, the system also includes a routine controller that is configured to initiate a protocol configured to provide user instructions to apply the attachment to a first body part until a thermal sensor senses that the first body part has reached a predetermined temperature.
In a preferred embodiment, the system is configured to determine at least one characteristic of the attachment. The at least one characteristic of the attachment may include a type of the attachment, a sensor of the attachment, and an actuator of the attachment. Preferably, the system also includes a wireless communication module configured to transmit the at least one characteristic to at least one of the percussive therapy device and a remote device.
In a preferred embodiment, the attachment includes a first set of electrical contacts. In a preferred embodiment, the distal end of the push rod assembly includes an attachment member that includes first and second balls biased outwardly therefrom. The first and second balls may be the first set of electrical contacts.
In accordance with another aspect of the present invention there is provided a method of providing at least one therapeutic effect to a user that includes obtaining a percussive therapy device that includes a housing, an electrical source, a motor positioned in the housing, a switch for activating the motor, a push rod assembly operatively connected to the motor and configured to reciprocate in response to activation of the motor, obtaining an attachment configured to be operatively connected to the percussive massage device and configured to provide at least one therapeutic effect to a user, and operating the percussive therapy device using the attachment. The at least one therapeutic effect may include vibration, percussion, heating, cooling, and exfoliation.
In a preferred embodiment, the attachment is further configured to obtain at least one of thermal data, blood-oxygen content data, blood flow data, angular position data, linear position data, and force magnitude data.
The method can also include the step of providing a recommendation to the user. In a preferred embodiment, the recommendation is generated from at least one of the thermal data, the angular position data, the linear position data, and the force magnitude data to assist in providing the at least one therapeutic effect to the user.
The method can also include the steps of providing the at least one therapeutic effect to a first body part of the user, monitoring a temperature of the first body part of the user, determining that the first body part of the user has reached a predetermined temperature, and providing user instructions to the user to cease providing the at least one therapeutic effect to the first body part when the first body part has reached the predetermined temperature. The at least one therapeutic effect may be provided in accordance with a protocol.
In a preferred embodiment, the method can further include the step of determining at least one characteristic of the attachment. The method can also include the step of providing a prompt communicating the at least one characteristic of the attachment to the user.
The invention may be more readily understood by referring to the accompanying drawings in which:
Like numerals refer to like parts throughout the several views of the drawings.
The following description and drawings are illustrative and are not to be construed as limiting. Numerous specific details are described to provide a thorough understanding of the disclosure. However, in certain instances, well-known or conventional details are not described in order to avoid obscuring the description. References to one or another embodiment in the present disclosure can be, but not necessarily are, references to the same embodiment; and, such references mean at least one of the embodiments.
Reference in this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the disclosure. Appearances of the phrase “in one embodiment” in various places in the specification do not necessarily refer to the same embodiment, nor are separate or alternative embodiments mutually exclusive of other embodiments. Moreover, various features are described which may be exhibited by some embodiments and not by others. Similarly, various requirements are described which may be requirements for some embodiments but not other embodiments.
The terms used in this specification generally have their ordinary meanings in the art, within the context of the disclosure, and in the specific context where each term is used. Certain terms that are used to describe the disclosure are discussed below, or elsewhere in the specification, to provide additional guidance to the practitioner regarding the description of the disclosure. For convenience, certain terms may be highlighted, for example using italics and/or quotation marks: The use of highlighting has no influence on the scope and meaning of a term; the scope and meaning of a term is the same, in the same context, whether or not it is highlighted. It will be appreciated that the same thing can be said in more than one way.
Consequently, alternative language and synonyms may be used for any one or more of the terms discussed herein. Nor is any special significance to be placed upon whether or not a term is elaborated or discussed herein. Synonyms for certain terms are provided. A recital of one or more synonyms does not exclude the use of other synonyms. The use of examples anywhere in this specification including examples of any terms discussed herein is illustrative only, and is not intended to further limit the scope and meaning of the disclosure or of any exemplified term. Likewise, the disclosure is not limited to various embodiments given in this specification.
Without intent to further limit the scope of the disclosure, examples of instruments, apparatus, methods and their related results according to the embodiments of the present disclosure are given below. Note that titles or subtitles may be used in the examples for convenience of a reader, which in no way should limit the scope of the disclosure. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure pertains. In the case of conflict, the present document, including definitions, will control.
It will be appreciated that terms such as “front,” “back,” “top,” “bottom,” “side,” “short,” “long,” “up,” “down,” and “below” used herein are merely for ease of description and refer to the orientation of the components as shown in the figures. It should be understood that any orientation of the components described herein is within the scope of the present invention.
While many embodiments are described herein, at least some of the described embodiments provide an apparatus, system, and method for a reciprocating treatment device.
As shown in
In a preferred embodiment, the battery 114 is housed in the second handle portion 145 and the motor 406 (
In a preferred embodiment, the first handle portion 143 has an interior edge 143a, the second handle portion 145 has an interior edge 145a and the third handle portion 147 has an interior edge 147a, which all cooperate to at least partially define the handle opening 149. As shown in
As shown in
The microcontroller unit 701, in an embodiment, is a microcontroller unit including a processor, a memory, and input/output peripherals. In other embodiments, however the microcontroller unit 701 is an ST Microelectronics STM32F030K6 series of microcontroller units, STM32F030C8T6 series of microcontrollers, STM32F030CCT6 series of microcontrollers, or an equivalent microcontroller.
One of ordinary skill would understand that the memory of the microcontroller unit 701 is configured to store machine-readable code for processing by the processor of the microcontroller unit 701. Various other configurations may exist depending on whether the designer of the percussive massage device with force meter 400 desires to implement the machine-readable code in software, firmware, or both. In an embodiment, the machine-readable code is stored on the memory and configured to be executed by a processor of the microcontroller 701. In an embodiment, the machine-readable code is stored on computer-readable media.
The battery pack management unit 702, in an embodiment, is implemented in firmware or software and configured to be used in connection with the microcontroller unit 701. In this embodiment, the firmware or software is stored in memory (not shown) and configured to be obtainable by the microcontroller unit 701. The battery pack management unit 702 may also be a combination of firmware, software, and hardware, in another embodiment. The battery pack management unit 702 is coupled with the NTC sensor 703. The NTC sensor 703 is a negative temperature coefficient thermistor used by the battery pack management unit 702 to sense temperature of the battery pack. For example, the NTC sensor 703 is a thermistor with B value of 3950+/−1%, and a resistance of 10 kΩ. In another example, the thermistor has a resistance of 100 kΩ. One of ordinary skill in the art would recognize that a thermistor is a resistor whose resistance is dependent upon temperature. In other embodiments, however, the NTC sensor 703 may be another type of temperature sensing device or component used in connection with the battery pack management unit 702.
The power charging management unit 704, in an embodiment, is implemented in firmware or software and configured to be used in connection with the microcontroller unit 701. Similarly to the battery pack management unit 702, the power charging management unit 704 firmware or software is stored in memory (not shown) and configured to be obtainable by the microcontroller unit 701. The power charging management unit 704 may also be a combination of firmware, software, and hardware, in another embodiment. In various embodiments, the power charging management unit 704 is configured to charge a battery pack via a direct connection or through an external charger, such as when configured to be operable with rechargeable batteries.
The wireless charging management unit 705, in an embodiment, is coupled to the battery pack management unit 702 and the battery charging inputs 708. In other embodiments, the battery or battery pack is charged using other conventional methodologies, such as, for example, charging the battery or battery pack using a wire or cord coupled to the battery charging inputs 708.
The wireless charging receiving system 706, in an embodiment, is coupled to the power charging management unit 704 and the display 709. The wireless charging receiving system 706 includes one or more of firmware, software, and hardware. In an embodiment, the wireless charging receiving system 706 is configured to receive information pertaining to battery capacity, charging metrics, and other information pertaining to wireless charging, and to pass along the information to the power charging management unit 704. The wireless charging receiving system 706 preferably includes a wireless charging pad used to charge the percussive massage device with force meter 400. One of ordinary skill in the art would understand that a variety of wireless charging devices may be utilized to wirelessly charge the percussive massage device with force meter 400. As one example, the Qi wireless charging standard and related devices may be utilized to wirelessly charge the percussive massage device with force meter 400.
The voltage management unit 707, in an embodiment, is a DC voltage regulator that steps down 5 volt to 3.3 volt power for use by the microcontroller unit 701. The voltage management unit 707 may also perform additional functions for management of 3.3 volt power for use by the microcontroller unit 701. In an embodiment, the voltage management unit 707 is implemented using a series of electronic components such as, for example, implementing a resistive divider using electronic components. In another embodiment, the voltage management unit 707 is a stand-alone voltage regulator module and/or device designed to step down voltage from 5 volts to 3.3 volts. One of ordinary skill in the art would understand the various methodologies and devices available to step down 5 volts to 3.3 volts.
The battery charging inputs 708, in an embodiment, are interfaces by which a wire or cord may be inserted for charging the percussive massage device with force meter 400. For example, a standardized barrel connector is the battery charging inputs 708. In another example, the battery charging inputs 708 is a USB connector. Other more specialized charging methodologies may require a particular battery charging input not described above.
The display 709, in an embodiment, displays a series of LEDs depicting an amount of force applied by the percussive massage device with force meter 400. In an alternative embodiment, the display 709 displays a series of LEDs depicting the current battery or battery pack charge of the percussive massage device with force meter 400. In yet another embodiment, the display 709 displays a series of LEDs depicting the current speed of the percussive massage device with force meter 400. One of ordinary skill in the art would recognize that while LEDs have been specified in the above-referenced embodiments, other embodiments not using LEDs are within the scope of this disclosure, such as, for example, liquid crystal displays, OLEDs, CRT displays, or plasma displays. One of ordinary skill in the art would also understand that it may be advantageous in an embodiment utilizing a battery or battery pack to use low-power options to ensure battery power longevity. In an embodiment, the display 709 is a 128×64 pixel OLED display.
The wireless control unit 710 is a wireless connectivity device that may be implemented in a wireless microcontroller unit. In an embodiment, the wireless control unit 710 is a Bluetooth transceiver module configured to couple, via Bluetooth, to a remote device. In an embodiment, the Bluetooth module is a Bluetooth Low-Energy (BLE) module configured to be run in broadcast mode. The wireless control unit 710 is coupled to the microcontroller unit 701. In an embodiment, the remote device is a smartphone having an embedded Bluetooth module. In an alternative embodiment, the remote device is a personal computer having Bluetooth connectivity. In other embodiments, other wireless connectivity standards besides the Bluetooth wireless standard may be utilized. It will be appreciated that the Bluetooth connectivity or other wireless connectivity may be described herein as being implemented in a wireless connection device. The wireless connection device can be a separate module, can be included in the MCU or other component of the device, or can be a separate chip. In summary, the percussive therapy device including a wireless connection device means that the percussive massage device can connect to another electronic device wirelessly (e.g., a phone, tablet, computer, computer, voice controlled speaker, regular speaker, etc.). One of ordinary skill in the art would recognize that low-power wireless control modules may be advantageous when the percussive massage device with force meter 400 is utilizing a battery or battery pack.
The OLED screen 711 and the OLED screen control system 712, in an embodiment, are configured to display substantially the same information as the display 709 referenced above. The OLED screen 711 is coupled to the OLED screen control system 511. The OLED screen control system 712 is coupled to the microcontroller unit 701, the OLED screen 711, and the power switch unit 717. In an embodiment, the display 709 and the OLED screen 711 may be redundant and it may only be necessary to utilize one or the other.
The motor 713, in an embodiment, is a brushless direct current (BLDC) motor. The motor 713 and the motor drive system 714, in an embodiment, are configured to vary the speed (i.e., rotational motion) that may be converted to reciprocal motion. In other embodiments, the motor 713 is a brushed DC motor, a brushed AC motor, or a brushless AC motor. One of ordinary skill in the art would understand that choosing a brushless or brushed motor, or direct current or alternating current, may vary depending on the application and intended size, battery power, and use.
The PWM speed setup unit 715, in an embodiment, is used to control pulse width modulation utilized to drive the motor 713. The PWM speed setup unit 715 is coupled to the microcontroller unit 701 and the over-current protection unit 716. One of ordinary skill in the art would understand that pulse width modulation is one way to vary the average power applied to the motor 713, resulting in varying speed as desired. In alternative embodiments, one of ordinary skill in the art would understand that there are a variety of methods to vary the speed of a brushless DC motor. For example, voltage to the motor 713 may be controlled in other non-PWM methods.
The over-current protection unit 716, in an embodiment, may be a feature of an integrated system-in-package to prevent damage caused by high currents to the motor. In other embodiments, the over-current protection unit 716 is implemented using a series of electronic components configured to protect the motor from excessively high current.
The power switch unit 717, in an embodiment, is configured to turn on and turn off the percussive massage device with force meter 400. The power switch unit 717 is coupled to the OLED screen control system 712 and the microcontroller unit 701. In an embodiment, the power switch unit 717 is the switch 405.
At Step 804, a lookup table is generated that correlates voltage V to force magnitude F. In an embodiment, the lookup table is generated using a method 900 of generating a lookup table correlating voltage to force. For example, the force magnitude F may be expressed in pounds of force. In an alternative embodiment, the force magnitude F may be expressed in Newtons of force.
At Step 806, the force magnitude F corresponding to voltage magnitude V is displayed on the percussive massage device with force meter 400. In an embodiment, a series of LED lights may be utilized to depict varying amounts of force as the force is being applied by the percussive massage device with force meter 400. Thus, as the amount of force magnitude F increases, more LEDs on the series of LED lights will be lit. Preferably, the series of LED lights consists of 12 LED lights.
At Step 904, a maximum magnitude of voltage, VMAX, is determined. The magnitude of VMAX may be determined by assessing the maximum theoretical voltage change possible by the percussive massage device with force meter 400. As an example, VMAX is 1.8 volts.
At Step 906, FMAX is divided into equal increments. Using the above example from Step 902, 60 pounds of force is divided into 60 one-pound increments.
At Step 908, VMAX is divided into the same amount of increments as determined in Step 906 above. Thus, using the above example from Step 904, 1.8 volts is divided into 60 0.03-volt increments.
At Step 910, a lookup table (LUT) is generated that correlates the increments of pounds of force with the increments of voltage. This necessarily creates a linear relationship between force and voltage.
A problem may arise in that the theoretical maximum voltage assumption at Step 904 in the method 900 is inaccurate. It may also be the case that as the percussive massage device with force meter 400 is used, the maximum available voltage degrades over time. In other words, the battery or battery pack voltage may decrease.
Accordingly, a method 1000 of calibrating the LUT generated by method 900 may be advantageous.
At Step 1004, VMAX is set to the actual battery voltage magnitude BV output. As an example, may decrease from 1.8 volts to 1.74 volts, a 0.6 volt decrease. At Step 1006, the LUT linear correlation is adjusted to reflect the lower VMAX.
At Step 1104, the display on the percussive massage device with force meter 400 that displays the force magnitude F is read to determine the force magnitude F corresponding to the measured battery pack voltage BV.
At Step 1106, a force meter is used to measure actual force being applied. In an embodiment, the force meter is a push/pull force meter. The direct measurement of force allows calibration of the LUT by comparing the displayed force magnitude F with the measured actual force. At Step 1108, the LUT is updated with a corrected force corresponding with the measured battery pack voltage BV. After Step 1108, Steps 1102-1106 are repeated for each successive voltage increment. In the embodiment depicted in accordance with the method 900, Steps 1102-1106 are repeated for every 0.03-volt increment.
At Step 1210, the force magnitude F corresponding to power magnitude P is displayed on the percussive massage device with force meter 400. In an embodiment, a series of LED lights may be utilized to depict varying amounts of force as the force is being applied by the percussive massage device with force meter 400. Thus, as the amount of force magnitude F increases, more LEDs on the series of LED lights will be lit. Preferably, the series of LED lights consists of 12 LED lights.
Total EPMAX=PMAX×Total EP Equation 1:
Equation 2 may be utilized to calculate Total EP, which is then input into Equation 1 above.
Total EP=EPBATTERY×EPPCBA×EPMOTOR Equation 2:
where Total EP, EPBATTERY, EPPCBA, and EPMOTOR are all expressed in percentages, and where PCBA is a printed circuit board assembly.
In an embodiment, EP (Battery) is 85%, EP (PCBA) is 95%, and EP (Motor) is 75%. Thus, using Equation 2, Total EP is 85%*95%*75%=60.5625%.
In this embodiment, PMAX is calculated by multiplying the maximum voltage VMAX and the maximum amperage CMAX of the battery pack such as in Equation 3. PMAX is then input into Equation 1.
PMAX=VMAX×CMAX
In this embodiment, VMAX is 16.8 volts and CMAX is 20 amperes. Thus, PMAX is 336 watts.
Turning back now to Equation 1, if PMAX is 336 watts and Total EP is 60.5625%, then Total EPMAX is 203 watts.
At Step 1304, a minimum amount of power PMIN, is determined. It will be recognized by one of ordinary skill in the art that the power without any force being applied (i.e., no load) will be non-zero. Thus, PMIN of 12 watts is assumed. One of ordinary skill will also understand that the value of is equivalent to the rated power without load, which may be derived from VMAX and CMIN.
At Step 1306, a maximum magnitude of force, FMAX, is determined. The magnitude of FMAX may be determined by assessing the maximum desired force to apply using the percussive massage device with force meter 400. As an example, FMAX is 60 pounds of force.
At Step 1308, Total EPMAX is divided into equal increments. In an embodiment, Total EPMAX is divided in 3 watt increments per one pound of force, starting at PMIN (12 watts). It will be recognized by one of ordinary skill in the art that if FMAX is 60 pounds of force, the total desired force output of the percussive massage device with force meter 400, then 60 pounds of force correlates to 189 watts, within the calculated Total EPMAX.
At Step 1310, a LUT is generated that correlates the increments of pounds of force with the increments of power in watts. This necessarily creates a linear relationship between force and voltage.
Similarly to the method 900, a problem may arise in that the measured voltage of the battery pack at Step 1204 in the method 1200 is inaccurate. It may also be the case that as the percussive massage device with force meter 400 is used, the maximum available voltage degrades over time. In other words, the battery or battery pack voltage may decrease.
At Step 1404, battery pack voltage BV is measured. In an embodiment, the measurement is done without applying any force from the percussive massage device with force meter 400. In an embodiment, the battery pack voltage BV is measured using an external voltage meter. In another embodiment, the battery pack and/or microcontroller unit 701 have embedded solutions for directly measuring battery pack voltage BV. At Step 1406, power is calculated using the product of C and BV. In an embodiment, the microcontroller unit 701 is configured to calculate power by multiplying C and BV.
At Step 1408, the display on the percussive massage device with force meter 400 that displays the force magnitude F is read to determine the force magnitude F corresponding to the calculated power. At Step 1410, a force meter is used to measure actual force being applied. In an embodiment, the force meter is a push/pull force meter. The direct measurement of force allows calibration of the LUT by comparing the displayed force magnitude F with the measured actual force. At Step 1412, the LUT is updated with a corrected force corresponding with the measured power. After Step 1412, Steps 1402-1410 are repeated for each power or force increment. In the embodiment depicted in accordance with the method 900, Steps 1402-1410 are repeated for every 3-watt increment.
As shown in
In a preferred embodiment, the device includes a push rod or shaft 14 that is connected directly to a shaft 16 that is rotated by the motor 406 and the motor shaft 21 extending therefrom. The shaft 16 can be part of a counterweight assembly 17 that includes a counterweight 19. In a preferred embodiment, the push rod 14 is L-shaped or includes an arc shape, as shown in
In a preferred embodiment, device 400 includes a number of dampening components that are made of an elastomer or the like and damp vibrations to keep the device relatively quiet. For example, as shown in
As shown in
In a preferred embodiment, the device 400 is associated with and can be operated by an app or software that runs on a mobile device such as a phone, watch or tablet (or any computer). The app can connect to the device 400 via bluetooth or other wireless connection protocol. The app can have any or all of the following functions. Furthermore, any of the functions discussed herein can be added to the touch screen/scroll wheel or button(s) capability directly on the device. If the user walks or is located too far away from the device, the device will not work or activate. The device can be turned on an off using the app as well as the touch screen or button on the device. The app can control the variable speeds (e.g., anywhere between 1750-3000 RPM). A timer can be implemented so the device stops after a predetermined period of time.
In a preferred embodiment the device, via the app or the touch screen and other functional buttons, etc. includes different treatment protocols or routines associated therewith. During the routine, the device can vary different aspects or outputs of the device or make changes based on time, speed (frequency), amplitude (stroke), arm position, force, temperature, grip (i.e., which handle portion to grip), attachment (e.g., cone, ball, dampener, etc.) and body part. The device (via the app, touch screen, haptic feedback or audibly via a speaker) can also prompt the user to make some of these changes at certain points throughout the routine, e.g., arm position, grip, attachment changes and body part changes. One of ordinary skill in the art will understand that, depending upon the particular design of the device, one or more of these outputs are applicable, while in other devices, all options described are applicable.
When the start of the protocol is selected, the device runs through a preprogrammed routine. For example, the device may operate at a first RPM for a first period of time and then operate at a second RPM for a second period of time and/or at a first amplitude for a first period of time and then operate at a second amplitude for a second period of time. The routines can also include prompts (e.g., haptic feedback) for letting the user to know to move to a new body part. These routines or treatments can be related to recovery, blood flow increase, performance, etc. and can each include a preprogrammed routine or protocol. These routines can also help facilitate certain activities, such as sleep, interval training, stairs, post-run, post-workout, recovery, wellness, post-core exercise, high intensity (plyometric) workouts, among others. The routines can also assist in providing relief and recovery from ailments such as plantar fasciitis, “tech neck,” muscle cramps, jet lag, sciatica, carpal tunnel, knots, and shin splints, among others. The routines can also prompt or instruct the user to switch attachments (e.g., attachment 628 shown in
Referring again to
The routine controller 630 is configured to perform a routine in connection with one or more specified protocols. The routine controller 630 can be, for example, the microcontroller unit 701 depicted in
One of ordinary skill in the art would understand that the force to be applied by the device 400 may depend upon the pressure exerted by the user in pressing the attachment onto a person's body part. As described more fully herein, the force to be applied by the device 400 may be the target force. In an embodiment where the user provides pressure to exert a particular force upon a person's body part, the routine controller 630 may adjust the output of the device 400 to ensure that the force actually applied by the attachment is the target force. The routine controller 630 may also be configured to provide feedback to the user to increase or decrease pressure on a person's body part to meet the target force. Each of these embodiments is applicable to each of the steps of a given protocol, including in Steps 2-4 below, as well as Steps 1-4 of the protocol shown in
Step 1 also specifies that the device 400 is to be operated using grip 1. Grip 1, for example, may be a grip on the first handle portion 143, otherwise referred to as a “regular” or “standard” grip. Grip 2, for example, may be a grip on the third handle portion 147, otherwise referred to as a “reverse” grip. An “inverse” grip can also be used on third handle portion 147. Grip 3, for example, may be a grip shown on the second handle portion 145, otherwise referred to as a “base” grip.
At Step 2, Protocol 1 specifies that the device 400 be activated for 15 seconds at 2100 RPM, with an amplitude of “3”, a force of “3”, and a temperature of 26° C. Step 2 specifies that the small ball attachment 628 be used, and that the device 400 is to be operated using grip 1. Step 2 therefore requires that the dampener attachment in Step 1 be replaced by the small ball attachment, but specifies that the same grip is to be used.
At Step 3, Protocol 1 specifies that the device 400 be activated for 30 seconds, at 2200 RPM, with an amplitude of “1”, a force of “3”, and a temperature of 29° C. Step 3 specifies that the dampener attachment 628 be used, and that the device 400 is to be operated using grip 1. Step 3 therefore requires that the small ball attachment in Step 2 be replaced by the dampener attachment, but specifies that the same grip is to be used.
At Step 4, Protocol 1 specifies that the device 400 be activated for 45 seconds, at 2400 RPM, with an amplitude of “4”, a force of “2”, and a temperature of 32° C. Step 3 specifies that the large ball attachment be used, and that the device 400 is to be operated using grip 1. Step 3 therefore requires that the dampener attachment in Step 2 be replaced by the large ball attachment, but specifies that the same grip is to be used. It will be appreciated that Protocol 1 is provided as an example to the reader of many of the different outputs that can be changed during a myriad of treatment protocols that can be provided or developed. It will be further appreciated that any one or more of the outputs can be a part of a protocol or routine and any of the outputs discussed herein can be omitted. For example, a protocol may only include time and speed or only time speed and force, or only time, speed and grip or any other combination of the outputs described herein.
Step 1 also specifies the arm position to be used is arm position 1. One of ordinary skill in the art would understand that the numbers of arm position (e.g., 1, 2, 3, 4, etc.) are predetermined arm positions intended to be used during a particular protocol. The part of the body to which the attachment 628 is to be applied is one of the factors in determining an optimal arm position. The arm position, however, may be determined by the user and is not required to otherwise implement a protocol. As discussed above, a “standard” grip may be utilized with arm position to apply to specific parts of the body, a “reverse” grip may be utilized with arm position to apply to specific parts of the body, and a “base” grip may be utilized with arm position to apply to specific parts of the body. One of ordinary skill in the art would recognize that the any arm position in combination with the particular grip 143, 145, 147 may vary depending on the application. One of ordinary skill in the art will understand that setting the arm position of a device 400 depends upon the specific device. For example, certain devices may allow a user to adjust arm position while others do not. For those that do not, this step does not apply. In other embodiments, this step may be performed during execution of the steps of the particular protocol.
At Step 2, the Shin Splints protocol specifies that the device 400 be activated for 1 minute at 1500 RPM, with an amplitude of “1”, a force of “2”, and a temperature of 21° C. Step 2 specifies that the dampener attachment be used, and that the device 400 is to be operated using grip 2 (“Reverse”), at an arm position 1, to the left shin. Step 2 therefore uses the same attachment, grip, and arm position as Step 1, but is applied to the other shin.
At Step 3, the Shin Splints protocol specifies that the device 400 be activated for 1 minute at 2000 RPM, with an amplitude of “3”, a force of “3”, and a temperature of 24° C. Step 2 specifies that the dampener attachment be used, and that the device 400 is to be operated using grip 3 (“Base”), at an arm position 1, to the right calf. Step 3 therefore requires that the user change grips from “reverse” to “base” grips, but specifies that the same attachment and arm position be used.
At Step 4, the Shin Splints protocol specifies that the device 400 be activated for 1 minute at 2000 RPM, with an amplitude of “3”, a force of “3”, and a temperature of 24° C. Step 2 specifies that the dampener attachment be used, and that the device 400 is to be operated using grip 3 (“Base”), at an arm position 1, to the left calf. Step 2 therefore uses the same attachment, grip, and arm position as Step 1, but is applied to the other calf.
At Step 1504, a user is prompted to set the arm position to the specified arm position. The user may be the person using the device 400 on their own body or on the body of another person. The arm position specified in the Shin Splints Protocol is arm position 1, for example.
At Step 1506, the user is prompted to use a specified grip or handle portion 143, 145, 147 on the device 400. The grip specified in the Shin Splints Protocol is the third handle portion 147, for example. As described herein, the grip may vary depending on the particular protocol or step.
At Step 1508, the user is prompted to affix a specified attachment to the device 400. As described herein, the attachment may vary depending on the particular protocol or step.
At Step 1510, the method determines whether the arm position and the grip position 143, 145, 147 are configured appropriately and whether the attachment 628 is affixed. Step 1510 may involve a prompt to the user by haptic feedback, application interface, or touch screen (among other types of prompts) in which the user is asked to proceed when the appropriate arm position, grip, and attachment are ready. In other embodiments, the device 400 may sense that the arm position and grip are appropriate and that an attachment is affixed before proceeding automatically. In an embodiment, Step 1510 is repeated until the arm position, grip, and attachment are ready.
At Step 1512, Step 1 of the protocol is initiated. Step 1, for example, is Step 1 depicted in
At Step 1514, the method 1500 applies a specified time period (T1) in which the device 400 is activated, a speed of the attachment, an amplitude of the attachment, a force of the attachment, and a temperature of the attachment. In an embodiment, one or more of these outputs of the device 400 are applied. These outputs may be applied by the routine controller 630. One of ordinary skill in the art would understand that a user's implementation of the device 400 on a body part is not required to apply certain of these outputs. For example, the time period, speed, amplitude, and temperature are not necessarily dependent upon a user applying pressure to a body part. On the other hand, the force applied by the attachment 628 may require a user to exert pressure on a body part for a target force (or a target force range) to be reached. Further, the temperature may vary depending on whether the attachment 628 is applied to a body part, or not, and to which body part it is applied. Thus, the temperature may need to be adjusted during application of the attachment 628 to reach a desired temperature predetermined by the protocol. In another embodiment, the temperature may be adjusted by a user.
After time period T1, the user may be prompted to change the attachment 628, arm position, and/or grip position 143, 145, 147. These outputs may need to be implemented prior to the start of Step 2 of a protocol. In the Shin Splints Protocol depicted in
At Step 1518, the user is prompted to use a specified grip 143, 145, 147 on the device 400. As described herein, the grip may vary depending on the particular protocol or step.
At Step 1520, the user is prompted to affix a specified attachment 628 to the device 400. As described herein, the attachment 628 may vary depending on the particular protocol or step.
At Step 1522, the method determines whether the arm position and the grip position 143, 145, 147 are configured appropriately and whether the attachment 628 is affixed. This step and all other like steps are optional. Step 1510 may involve a prompt to the user by haptic feedback, application interface, or touch screen (among other types of prompts) in which the user is prompted to move to the next step in the routine and/or requested to proceed when the appropriate arm position, grip, and attachment are ready. In other embodiments, the device 400 may sense that the arm position and grip are appropriate and that an attachment is affixed before proceeding automatically. In an embodiment, Step 1522 is repeated until the arm position, grip, and attachment are ready.
At Step 1524, Step 2 of the protocol is initiated. Step 2, for example, is Step 2 depicted in
At Step 1526, the method 1500 applies a specified time period (T2) in which the device 400 is activated, a speed of the attachment, an amplitude of the attachment, a force of the attachment, and a temperature of the attachment. In an embodiment, one or more of these outputs of the device 400 are applied. These outputs may be applied by the routine controller 630. One of ordinary skill in the art would understand that a user's implementation of the device 400 on a body part is not required to apply certain of these outputs. For example, the time period, speed, amplitude, and temperature are not necessarily dependent upon a user applying pressure to a body part. On the other hand, the force applied by the attachment 628 may require a user to exert pressure on a body part for a target force to be reached. Further, the temperature may vary depending on whether the attachment 628 is applied to a body part, or not, and to which body part it is applied. Thus, the temperature may need to be adjusted during application of the attachment 628 to reach a desired temperature predetermined by the protocol. In another embodiment, the temperature may be adjusted by a user.
After time period T2, the user may be prompted to change the attachment 628, arm position and/or grip position 143, 145, 147. These outputs may need to be implemented prior to the start of Step 3 of a protocol. In the Shin Splints Protocol depicted in
At Steps 1528-1534, therefore, steps substantially the same as Steps 1516-1522 are performed. After Step 1534, Steps 3-4 are initiated in substantially the same manner as Steps 1-2. For example, Steps 3 and 4 may be Steps 3 and 4 of the Protocol 1 depicted in
As an alternative to
Steps 1536-1538 are performed substantially the same as Steps 1524-1526 in previous Step 2 above.
At Step 1540, the force being applied by the attachment 628 is monitored. In the embodiment shown in
At Step 1542, the force is displayed to the user. In an embodiment, the force is displayed on an application interface 1584 such as a graphical user interface. In other embodiments, individual use or combined use of the application interface 1584, touch screen 1582, the OLED screen 711, or the like, may be used to display the force.
At Step 1546, the user is prompted to increase or decrease the force being applied to a body part according to the specified protocol during T2.
After time period T2, the user may be prompted to change the attachment 628, arm position and/or grip position 143, 145, 147. These outputs may need to be implemented prior to the start of Step 3 of a protocol. In the Shin Splints Protocol depicted in
At Steps 1548-1552, therefore, steps substantially the same as Steps 1516-1522 are performed. After Step 1534, Steps 3-4 are initiated in substantially the same manner as Steps 1-2. For example, Steps 3 and 4 may be Steps 3 and 4 of the Protocol 1 depicted in
The next portion of the interface 1584 shows step fields 1558-1568 of the protocol that are displayed to the user. In this embodiment, the step fields identify the title of the step and time period of the step. For example, step field 1558 is titled “RIGHT BICEP” (where the treatment will be provided) and the time period of activation is “0:30 MIN.”
The interface 1584 also includes a current step field 1570 that identifies the current step title 1570, a grip title display 1572, and an attachment title display 1574.
The interface 1584 also includes a time display 1576 and a time remaining display 1578 to show the user how much time has occurred during that step and the time remaining in that step. Finally, the interface 1584 includes a control field 1580 to play, skip back, and skip forward from step to step.
As described above,
Furthermore, the motor mount 401 mounts the motor 402 so that the motor shaft axis A4 (the rotation axis), extends forwardly and backwardly with respect to the orientation of the device 457 in use. This direction is also considered longitudinally. The motor shaft axis A4 (or a plane defined by the motor shaft axis) bisects the housing 101.
In a preferred embodiment, the temperature reading capability is integrated with and a part of the treatment routines or protocols described herein. For example, instead of a routine or a step within a routine running or extending for a predetermined period of time, the routine or step (i.e., the amount of time a particular muscle or body part is treated or targeted) can extend until the muscle or body part (referred to generally herein as a body part) reaches a predetermined temperature. Accordingly, reaching a predetermined temperature can be substituted for predetermined period of time for any of the routines discussed herein. For example, step 1526 in
As shown in
As shown in
In another preferred embodiment, any of the devices taught herein can include a mechanism for heating or changing the temperature of the attachment (massage element, treatment structure, Ampbit) on the end of the reciprocating shaft. The attachment can include an electrical resistance element therein that is provides to heat to the muscles. In a preferred embodiment, the electrical resistance element is connected to the PCB via a hollow shaft. The two outwardly biased metal spring balls on the male connector act as the electrical connector to the attachment.
In use, an electrical connection is made when the massage member 508 is secured to the device and to the male attachment member 110. When heating or cooling is turned on, the heating element 502 in the massage member 508 is heated, which can then be applied to the user's body part. The heating element or electrical resistance member (e.g., heated pad) can be located in or on the massage member (e.g., ball, cone, etc.) and the metal connection between the male connector and the massage member is used to electrically connect to the battery.
The electrical connection between the male or female attachment member 110 permits a variety of uses beyond heating with the heating element 502. In a preferred embodiment, a heating element 502 radiates wavelengths to produce heat on a user's body part. The male or female attachment member 110, for example, may be utilized for a variety of other uses, such as vibration, percussion, cooling, and exfoliating. The male or female attachment member 110 may be configured as an actuator designed to provide these uses. For example, percussion is already achieved using the attachment 628. However, the attachment 628 or 508 may be modified to add or replace the heating element 502 with a cooling, vibration, or exfoliating element. Other uses and actuators may be utilized without departing from the scope of the present invention.
As shown in
In an embodiment, the printed circuit board 408 of the device 100 powers the angular position sensor 516 and a linear position sensor 518 and stores the data the sensors generate. For example, the sensor data may be stored in a memory (not shown). In another embodiment, the PCB 408 integrally incorporates the sensor chipboard 504. Preferably, the PCB 408 broadcasts and/or transmits data generated by the sensors through a wireless connectivity standard, such as Bluetooth. For example, the wireless connectivity standard is implemented via the wireless control unit 710 (
In a preferred embodiment, the angular and linear position sensors 516, 518, coupled with the force meter of the percussive therapy device 400 discussed above, can be used to map the treatment of a muscle or body part as the device 400 is being used in a three-dimensional display. This “map” or data can be displayed through or on an application or on the touch screen 1582. For example, angular and linear position data obtained from the angular and linear position sensors 516, 518 can be graphically represented via the application or on the touch screen 1582. The angular and linear position data can assist the user in applying a particular protocol or routine, for example, such as those depicted in
Referring again to
As an example, while a user's quad muscle is not a uniform shape, it is possible to simplify the user's quad muscle to the shape of a cylinder. The angular and linear position can be ascertained, and thus, a determination can be made concerning how the device 400, 457 is positioned relative to the cylinder. Further, a determination can be made concerning the direction the percussive arm (e.g., push rod assembly 14, shaft 16, and/or attachment 628) is directed of the device 400, 457. The determination can also be made concerning how the device is moving relative to the cylinder in linear coordinates. The force magnitude from the force meter of the device 400, 457 allows confirmation that the device 400, 457 is in contact with the muscle, as well as the intensity and duration of that interaction.
Similarly, the device 400, 457 can also include a thermal sensor 462 or thermometer 462 that can determine the temperature of the user's muscle and to provide feedback to the device and/or application. See
In an embodiment, a three-dimensional rendering of thermal readings from the thermal sensor 462 is provided to a user to show incremental increases in temperature over time. For example, a three-dimensional rendering may show varying colors from blue (e.g., cool) to yellow/orange (e.g., medium temperature) to red (e.g., hot) to illustrate to the user the increase in temperature over time.
An accessory, module or attachment module 520 can be used with and attached or secured to a percussive massage or percussive therapy device 100, 400, 457 as part of a percussive therapy system 500. In a preferred embodiment, the attachment module 520 includes a thermal sensor or thermometer 462 that can determine the temperature of the user's muscle and to provide feedback to a device and/or application. In a preferred embodiment, the thermal sensor 462 allows the application to determine or customize the timing of each step within a protocol. The temperature can be used to determine blood flow and therefore muscle readiness for a specific goal (e.g., relaxation, performance, focus).
As shown in
As described above with respect to
In a preferred embodiment, the attachment module 520 communicates wirelessly with the percussive therapy device 400 and/or the application on the user's mobile device. See
Referring again to
In a preferred embodiment, the temperature reading capability is integrated with and a part of the treatment routines or protocols described herein or by reference. For example, instead of a routine or a step within a routine running or extending for a predetermined period of time, the routine or step (i.e., the amount of time a particular muscle or body part is treated or targeted) can extend until the muscle or body part (referred to generally herein as a body part) reaches a predetermined temperature. Accordingly, reaching a predetermined temperature can be substituted for predetermined period of time for any of the routines. For example, step 1526 in
In a preferred embodiment, the attachment module 520 includes an angular position sensor 516 (e.g., gyroscope 516) and/or a linear position sensor 518 (e.g., accelerometer 518). Each or both can be implemented as part of the PCB 18. One or more gyroscopes 516, accelerometers 518, sensors or the like can be included on or in the device 400 for detecting and gathering data. One or more actuators may also be included on or in the device 400 for providing at least one therapeutic effect. Thus, the description above referencing gyroscopes, 516, accelerometers 518, attachments 628, 508, male or female attachment members 110, or sensors or actuators within or without the housing 101 is instructive and within the scope of the attachment module 520. See
In an embodiment, the percussive therapy system 500 is configured to determine at least one characteristic of the attachment 628, 508. For example, a percussive therapy device 100, 400 itself may include circuitry and wired or wireless communication to sense the type of attachment the user intends to use in connection with the device 100, 400. For example, the device 100, 400 may sense that the attachment 628 is a dampener. Other characteristics of the attachment 628, 508 may be sensed. For example, the existence of one or more sensors included in the attachment 628, 508 may be sensed. In addition, the existence of one or more actuators included in the attachment 628, 508 may be sensed. In an embodiment, the device 100, 400 senses when the attachment 628, 508 is attached to a distal end of the push rod assembly 14. Once the attachment 628, 508 is attached, then the device may, through wired connections (e.g., positive/negative contacts 510, 512 or the like, or other wired electrical connections), sense the various characteristics of the attachment 628, 508. In this embodiment, the wired connections may communicate with the PCB 408, 504 so that the device 100, 400 determines the characteristics. In another embodiment, the attachment 628, 508 may include wireless communication capabilities and communicate the characteristics wirelessly. One of ordinary skill in the art would understand that there are a variety of methodologies to employ to communicate the characteristics to the device 100, 400 and/or the user, preferably through communication on a remote device or touch screen 1582.
At Step 1608, linear position data is obtained from an accelerometer 518 in three linear axes (x, y, z). The accelerometer may also be a linear position sensor 518 or suitable replacement. At Step 1610, adjustment of a linear position of the percussive massage device 400, 457 is recommended in response to the linear position data. For example, in
At Step 1612, force magnitude data is obtained from a force meter included in the percussive therapy device 400, 457. At Step 1614, application of the attachment 628 of device 400, 457 to the user's body part is recommended if the attachment 628 is not in contact with the user's body part in response to the force magnitude data. For example, the force magnitude is approximately zero (or a de minimus threshold amount) that may be predetermined if the attachment is not in contact with the user's body part.
At Step 1616, adjustment of a force magnitude exerted on the user by the attachment 628 of the device 400, 457 is recommended in response to the force magnitude data. For example, in
At Step 1618, a three-dimensional representation of the device 400, 457 and its angular and/or linear position and/or force magnitude is displayed on a display. The angular position of the device 400, 457, in an embodiment, is displayed similarly to the graphic shown in
At Step 1624, a temperature of the user's body part is monitored. At Step 1626, it is determined whether the temperature reading is greater than or equal to a predetermined threshold temperature. Once the temperature reaches the predetermined threshold temperature, for example, the user's body part is ready for exercise. This may vary depending on the user and the user's body part. If the temperature is less than the predetermined threshold temperature, Steps 1622 and 1624 are repeated. If the temperature is greater than or equal to the predetermined threshold temperature, then Step 1628 is implemented. At Step 1628, user instructions are provided to cease providing the therapeutic effect to the user's body part. The user's body part is warm enough to exercise safely and effectively with lower risk for exercise-related injury, and can also improve performance of the user during the exercise.
Although the operations of the method(s) herein are shown and described in a particular order, the order of the operations of each method may be altered so that certain operations may be performed in an inverse order or so that certain operations may be performed, at least in part, concurrently with other operations. In another embodiment, instructions or sub-operations of distinct operations may be implemented in an intermittent and/or alternating manner.
Unless the context clearly requires otherwise, throughout the description and the claims, the words “comprise,” “comprising,” and the like are to be construed in an inclusive sense, as opposed to an exclusive or exhaustive sense; that is to say, in the sense of “including, but not limited to.” As used herein, the terms “connected,” “coupled,” or any variant thereof, means any connection or coupling, either direct or indirect, between two or more elements; the coupling of connection between the elements can be physical, logical, or a combination thereof. Additionally, the words “herein,” “above,” “below,” and words of similar import, when used in this application, shall refer to this application as a whole and not to any particular portions of this application. Where the context permits, words in the above Detailed Description of the Preferred Embodiments using the singular or plural number may also include the plural or singular number respectively. The word “or” in reference to a list of two or more items, covers all of the following interpretations of the word: any of the items in the list, all of the items in the list, and any combination of the items in the list.
Embodiments are envisioned where any of the aspects, features, component or steps herein may be omitted and/or are option. Furthermore, where appropriate any of these optional aspects, features, component or steps discussed herein in relation to one aspect of the invention may be applied to another aspect of the invention.
The above-detailed description of embodiments of the disclosure is not intended to be exhaustive or to limit the teachings to the precise form disclosed above. While specific embodiments of and examples for the disclosure are described above for illustrative purposes, various equivalent modifications are possible within the scope of the disclosure, as those skilled in the relevant art will recognize. For example, while processes or blocks are presented in a given order, alternative embodiments may perform routines having steps, or employ systems having blocks, in a different order, and some processes or blocks may be deleted, moved, added, subdivided, combined, and/or modified to provide alternative or subcombinations. Each of these processes or blocks may be implemented in a variety of different ways. Also, while processes or blocks are at times shown as being performed in series, these processes or blocks may instead be performed in parallel, or may be performed, at different times. Further any specific numbers noted herein are only examples: alternative implementations may employ differing values or ranges.
The above-detailed description of embodiments of the disclosure is not intended to be exhaustive or to limit the teachings to the precise form disclosed above. While specific embodiments of and examples for the disclosure are described above for illustrative purposes, various equivalent modifications are possible within the scope of the disclosure, as those skilled in the relevant art will recognize. Further, any specific numbers noted herein are only examples: alternative implementations may employ differing values, measurements or ranges. It will be appreciated that any dimensions given herein are only exemplary and that none of the dimensions or descriptions are limiting on the present invention.
The teachings of the disclosure provided herein can be applied to other systems, not necessarily the system described above. The elements and acts of the various embodiments described above can be combined to provide further embodiments.
Any patents and applications and other references noted above, including any that may be listed in accompanying filing papers, are incorporated herein by reference in their entirety. Aspects of the disclosure can be modified, if necessary, to employ the systems, functions, and concepts of the various references described above to provide yet further embodiments of the disclosure.
These and other changes can be made to the disclosure in light of the above Detailed Description of the Preferred Embodiments. While the above description describes certain embodiments of the disclosure, and describes the best mode contemplated, no matter how detailed the above appears in text, the teachings can be practiced in many ways. Details of the system may vary considerably in its implementation details, while still being encompassed by the subject matter disclosed herein. As noted above, particular terminology used when describing certain features or aspects of the disclosure should not be taken to imply that the terminology is being redefined herein to be restricted to any specific characteristics, features or aspects of the disclosure with which that terminology is associated. In general, the terms used in the following claims should not be construed to limit the disclosures to the specific embodiments disclosed in the specification unless the above Detailed Description of the Preferred Embodiments section explicitly defines such terms. Accordingly, the actual scope of the disclosure encompasses not only the disclosed embodiments, but also all equivalent ways of practicing or implementing the disclosure under the claims.
While certain aspects of the disclosure are presented below in certain claim forms, the inventors contemplate the various aspects of the disclosure in any number of claim forms. For example, while only one aspect of the disclosure is recited as a means-plus-function claim under 35 U.S.C. § 112, ¶6, other aspects may likewise be embodied as a means-plus-function claim, or in other forms, such as being embodied in a computer-readable medium. (Any claims intended to be treated under 35 U.S.C. § 112, ¶6 will begin with the words “means for”). Accordingly, the applicant reserves the right to add additional claims after filing the application to pursue such additional claim forms for other aspects of the disclosure.
Accordingly, although exemplary embodiments of the invention have been shown and described, it is to be understood that all the terms used herein are descriptive rather than limiting, and that many changes, modifications, and substitutions may be made by one having ordinary skill in the art without departing from the spirit and scope of the invention.
This application is a continuation of U.S. patent application Ser. No. 17/739,630, filed May 9, 2022. U.S. patent application Ser. No. 17/739,630 is a continuation-in-part of U.S. patent application Ser. No. 17/244,239, filed Apr. 29, 2021, now U.S. Pat. No. 11,452,670. U.S. patent application Ser. No. 17/244,239 is a continuation-in-part of U.S. patent application Ser. No. 17/018,099, filed Sep. 11, 2020, now U.S. Pat. No. 11,357,697. U.S. patent application Ser. No. 17/244,239 claims the benefit of U.S. Provisional Application No. 63/133,951, filed Jan. 4, 2021. U.S. patent application Ser. No. 17/244,239 also claims the benefit of U.S. Provisional Application No. 63/017,472, filed Apr. 29, 2020. U.S. patent application Ser. No. 17/739,630 is also a continuation-in-part of U.S. patent application Ser. No. 17/705,300, filed Mar. 26, 2020. This application is also a continuation of U.S. patent application Ser. No. 17/244,278, filed Apr. 29, 2021. U.S. patent application Ser. No. 17/244,278 is also a continuation-in-part of U.S. patent application Ser. No. 17/018,099, filed Sep. 11, 2020, which is a continuation-in-part of U.S. patent application Ser. No. 16/869,402, filed May 7, 2020, now U.S. Pat. No. 10,857,064, which is a continuation-in-part of U.S. patent application Ser. No. 16/796,143, filed Feb. 20, 2020, now U.S. Pat. No. 10,940,081, which claims the benefit of U.S. Provisional Application No. 62/844,424, filed May 7, 2019, U.S. Provisional Application No. 62/899,098, filed Sep. 11, 2019 and U.S. Provisional Application No. 62/912,392, filed Oct. 8, 2019. U.S. patent application Ser. No. 16/869,402 is also a continuation-in-part of U.S. patent application Ser. No. 16/675,772, filed Nov. 6, 2019, which claims the benefit of U.S. Provisional Application No. 62/785,151, filed on Dec. 26, 2018. U.S. patent application Ser. No. 17/244,278 also claims the benefit of U.S. Provisional Application No. 63/133,951, filed Jan. 5, 2021 and U.S. Provisional Application No. 63/017,472, filed Apr. 29, 2020. All applications listed above are incorporated by reference herein in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
657765 | Gibbs | Sep 1900 | A |
675772 | Ferguson | Jun 1901 | A |
1545027 | Ashlock | Jul 1925 | A |
1594636 | Smith | Aug 1926 | A |
1657765 | Pasque | Jan 1928 | A |
1784301 | Mekler | Dec 1930 | A |
D91454 | Decker | Feb 1934 | S |
D93943 | Rand | Nov 1934 | S |
2179594 | Johnson | Nov 1939 | A |
D118980 | Larson | Feb 1940 | S |
D129045 | Wilhide | Aug 1941 | S |
2391671 | Berg | Dec 1945 | A |
D143678 | Snyder et al. | Jan 1946 | S |
2475861 | Alfred | Jul 1949 | A |
D161484 | McQuown | Jan 1951 | S |
D163324 | Rittenhouse | May 1951 | S |
D180923 | Anton | Sep 1957 | S |
D181742 | Madl et al. | Dec 1957 | S |
2931632 | Angelis et al. | Apr 1960 | A |
2987334 | Wendling | Jun 1961 | A |
3053559 | Norval | Sep 1962 | A |
3077837 | Sidney et al. | Feb 1963 | A |
D195145 | Ernest | Apr 1963 | S |
D197142 | Godfrey | Dec 1963 | S |
3172675 | Gonzalez | Mar 1965 | A |
D207505 | Whitman | Apr 1967 | S |
3452226 | Hettich | Jun 1969 | A |
3545301 | Richter | Dec 1970 | A |
3626934 | Andis | Dec 1971 | A |
3699952 | Waters et al. | Oct 1972 | A |
3705579 | Morini et al. | Dec 1972 | A |
D230522 | Rothman | Feb 1974 | S |
D237454 | Adams | Nov 1975 | S |
D237455 | Schramm | Nov 1975 | S |
3942251 | Griffies et al. | Mar 1976 | A |
3968789 | Simoncini | Jul 1976 | A |
4031763 | Eisenberg | Jun 1977 | A |
4046142 | Whitney | Sep 1977 | A |
4088128 | Mabuchi | May 1978 | A |
4150668 | Johnston | Apr 1979 | A |
4158246 | Meadows et al. | Jun 1979 | A |
4173217 | Johnston | Nov 1979 | A |
4203431 | Abura et al. | May 1980 | A |
D265985 | House, II | Aug 1982 | S |
4506159 | Reuter et al. | Mar 1985 | A |
4513737 | Mabuchi | Apr 1985 | A |
4533796 | Engelmore | Aug 1985 | A |
4549535 | Wing | Oct 1985 | A |
4565189 | Mabuchi | Jan 1986 | A |
4566442 | Mabuchi et al. | Jan 1986 | A |
4596406 | Van Vleet et al. | Jun 1986 | A |
D287814 | Hiraishi et al. | Jan 1987 | S |
4691693 | Sato | Sep 1987 | A |
4692958 | McMakin | Sep 1987 | A |
D292368 | Mikiya | Oct 1987 | S |
4730605 | Noble et al. | Mar 1988 | A |
D300132 | Culbertson et al. | Mar 1989 | S |
4815224 | Miller | Mar 1989 | A |
4841955 | Evans et al. | Jun 1989 | A |
D303373 | Ching, Jr. | Sep 1989 | S |
D310005 | Precht | Aug 1990 | S |
D314320 | Brosius et al. | Feb 1991 | S |
4989613 | Finkenberg | Feb 1991 | A |
4991298 | Matre | Feb 1991 | A |
5014681 | Heeman et al. | May 1991 | A |
D320379 | Culbertson | Oct 1991 | S |
D321338 | Sakamoto et al. | Nov 1991 | S |
5085207 | Fiore | Feb 1992 | A |
5088474 | Mabuchi et al. | Feb 1992 | A |
5092317 | Zelikovski | Mar 1992 | A |
5103809 | DeLuca et al. | Apr 1992 | A |
5123139 | Leppert et al. | Jun 1992 | A |
D329166 | Doggett | Sep 1992 | S |
D329291 | Wollman | Sep 1992 | S |
D329292 | Wollman | Sep 1992 | S |
D331467 | Wollman | Dec 1992 | S |
D334012 | Chen | Mar 1993 | S |
5201149 | Eisenblatter | Apr 1993 | A |
5207697 | Carusillo et al. | May 1993 | A |
5212887 | Farmerie | May 1993 | A |
D338802 | Maass | Aug 1993 | S |
D345077 | Maass | Mar 1994 | S |
D345727 | Flowers et al. | Apr 1994 | S |
D345888 | Joss et al. | Apr 1994 | S |
D349029 | Matsunaga et al. | Jul 1994 | S |
5417644 | Lee | May 1995 | A |
D363352 | Huen | Oct 1995 | S |
D367712 | Young | Mar 1996 | S |
5501657 | Feero | Mar 1996 | A |
D374934 | Lie | Oct 1996 | S |
5569168 | Hartwig | Oct 1996 | A |
5573500 | Katsunuma et al. | Nov 1996 | A |
5656017 | Keller et al. | Aug 1997 | A |
5656018 | Tseng | Aug 1997 | A |
D383366 | Heck | Sep 1997 | S |
D383435 | Svetlik | Sep 1997 | S |
D384639 | Kawakami et al. | Oct 1997 | S |
D387728 | Kawakami et al. | Dec 1997 | S |
D388175 | Lie | Dec 1997 | S |
D397991 | Kawakami et al. | Sep 1998 | S |
D400161 | Nagele et al. | Oct 1998 | S |
D400758 | Hippen et al. | Nov 1998 | S |
5860669 | Wass et al. | Jan 1999 | A |
D408543 | Back | Apr 1999 | S |
5910197 | Chaconas | Jun 1999 | A |
5925002 | Wollman | Jul 1999 | A |
D412485 | Kato et al. | Aug 1999 | S |
5935089 | Shimizu | Aug 1999 | A |
5951501 | Griner | Sep 1999 | A |
D417648 | Clowers et al. | Dec 1999 | S |
6003052 | Yamagata | Dec 1999 | A |
6006631 | Miner et al. | Dec 1999 | A |
D425014 | Willkens et al. | May 2000 | S |
D430774 | Naft et al. | Sep 2000 | S |
D430938 | Lee | Sep 2000 | S |
D432077 | Zurwelle et al. | Oct 2000 | S |
D433300 | Buck | Nov 2000 | S |
6146383 | Studer et al. | Nov 2000 | A |
6165145 | Noble | Dec 2000 | A |
D439984 | Thach | Apr 2001 | S |
D440136 | Buck | Apr 2001 | S |
6227959 | Beaudry | May 2001 | B1 |
6228042 | Dungan | May 2001 | B1 |
6228120 | Leonard et al. | May 2001 | B1 |
6245031 | Pearson | Jun 2001 | B1 |
6290660 | Epps et al. | Sep 2001 | B1 |
D448852 | Engelen | Oct 2001 | S |
6401289 | Herbert | Jun 2002 | B1 |
6406445 | Ben-Nun | Jun 2002 | B1 |
6432072 | Harris et al. | Aug 2002 | B1 |
6537236 | Tucek et al. | Mar 2003 | B2 |
6539328 | Cremonese et al. | Mar 2003 | B1 |
D474445 | Matsuoka et al. | May 2003 | S |
6558338 | Wasserman | May 2003 | B1 |
6568089 | Popik et al. | May 2003 | B1 |
D475595 | Hatch et al. | Jun 2003 | S |
D475679 | Cooper et al. | Jun 2003 | S |
D476746 | Harris et al. | Jul 2003 | S |
6599250 | Webb et al. | Jul 2003 | B2 |
6599260 | Tucek et al. | Jul 2003 | B2 |
D478385 | Dirks et al. | Aug 2003 | S |
D481279 | Buck | Oct 2003 | S |
6663657 | Miller | Dec 2003 | B1 |
6682496 | Pivaroff | Jan 2004 | B1 |
6715781 | Smith | Apr 2004 | B1 |
6723050 | Dow et al. | Apr 2004 | B2 |
6723060 | Miller | Apr 2004 | B2 |
6758826 | Luettgen et al. | Jul 2004 | B2 |
6805700 | Miller | Oct 2004 | B2 |
6823762 | Hu | Nov 2004 | B2 |
6846295 | Ben-Nun | Jan 2005 | B1 |
D504111 | Ozawa et al. | Apr 2005 | S |
D510317 | Sun | Oct 2005 | S |
6994575 | Clark et al. | Feb 2006 | B1 |
7041072 | Calvert | May 2006 | B2 |
D530270 | Ozawa et al. | Oct 2006 | S |
7128721 | Ferber et al. | Oct 2006 | B2 |
D531733 | Burout, III et al. | Nov 2006 | S |
7169169 | Tucek et al. | Jan 2007 | B2 |
7223250 | Brattesani et al. | May 2007 | B2 |
D544102 | Pivaroff | Jun 2007 | S |
D544436 | Kawahara et al. | Jun 2007 | S |
D547264 | Kondo | Jul 2007 | S |
D553252 | Masuda | Oct 2007 | S |
D553562 | Okada et al. | Oct 2007 | S |
7384405 | Rhoades | Jun 2008 | B2 |
D575224 | Taniguchi et al. | Aug 2008 | S |
7431706 | Louis | Oct 2008 | B2 |
D579868 | Harrison | Nov 2008 | S |
D580353 | Harrison et al. | Nov 2008 | S |
7470081 | Miyahara et al. | Dec 2008 | B2 |
D587977 | Waldron | Mar 2009 | S |
7497639 | Lebot et al. | Mar 2009 | B2 |
7503923 | Miller | Mar 2009 | B2 |
D593204 | Manke et al. | May 2009 | S |
7549966 | Fujii et al. | Jun 2009 | B2 |
D597482 | Kondo et al. | Aug 2009 | S |
D604235 | Tarter | Nov 2009 | S |
D605586 | Tong | Dec 2009 | S |
D606192 | Summerer et al. | Dec 2009 | S |
7731672 | Chiang | Jun 2010 | B2 |
7740249 | Gao | Jun 2010 | B1 |
D622660 | Taniguchi et al. | Aug 2010 | S |
7857729 | Sullivan et al. | Dec 2010 | B2 |
D631315 | Xue et al. | Jan 2011 | S |
7877880 | Royle | Feb 2011 | B2 |
7927259 | Rix | Apr 2011 | B1 |
7927294 | Kamimura et al. | Apr 2011 | B2 |
7963717 | Seger | Jun 2011 | B2 |
7996996 | Hirabayashi | Aug 2011 | B2 |
D649657 | Petersen et al. | Nov 2011 | S |
D658759 | Marescaux et al. | May 2012 | S |
D659644 | Gretz | May 2012 | S |
D666303 | Ding et al. | Aug 2012 | S |
8313450 | Ben-Nun | Nov 2012 | B2 |
8342187 | Kalman et al. | Jan 2013 | B2 |
D682195 | Aglassinger | May 2013 | S |
8435194 | Dverin et al. | May 2013 | B2 |
8479616 | Tsai | Jul 2013 | B2 |
8622943 | Ben-Nun | Jan 2014 | B2 |
8646348 | Hung | Feb 2014 | B2 |
D703337 | Fuhr et al. | Apr 2014 | S |
D703480 | Lownds | Apr 2014 | S |
8695461 | Moss et al. | Apr 2014 | B2 |
D706433 | Fuhr et al. | Jun 2014 | S |
D708742 | Dallemagne et al. | Jul 2014 | S |
8770882 | Ersoy | Jul 2014 | B2 |
8777881 | Tsai | Jul 2014 | B2 |
8864143 | Lin | Oct 2014 | B2 |
D722016 | Beukema | Feb 2015 | S |
8945104 | Boone, III et al. | Feb 2015 | B2 |
8951216 | Yoo et al. | Feb 2015 | B2 |
D726495 | Ryan | Apr 2015 | S |
9017273 | Burbank et al. | Apr 2015 | B2 |
D734863 | Hennessey | Jul 2015 | S |
D735348 | Hennessey | Jul 2015 | S |
9107486 | Brewer et al. | Aug 2015 | B2 |
9132058 | Imboden et al. | Sep 2015 | B2 |
9138257 | Revivo | Sep 2015 | B2 |
D740222 | Tang | Oct 2015 | S |
9272837 | Linzell | Mar 2016 | B2 |
D756180 | Chen | May 2016 | S |
D759237 | Heath et al. | Jun 2016 | S |
D759238 | Heath et al. | Jun 2016 | S |
9364385 | Yang | Jun 2016 | B2 |
D763442 | Price et al. | Aug 2016 | S |
9416805 | Cascolan et al. | Aug 2016 | B2 |
D776612 | Chen et al. | Jan 2017 | S |
D778439 | Håkansson et al. | Feb 2017 | S |
9597256 | Paul | Mar 2017 | B1 |
9744600 | Yang et al. | Aug 2017 | B2 |
9872813 | Giraud et al. | Jan 2018 | B2 |
9889066 | Danby et al. | Feb 2018 | B2 |
D817732 | Rettler | May 2018 | S |
D817869 | Lee et al. | May 2018 | S |
D819221 | Lei | May 2018 | S |
9981366 | Todd et al. | May 2018 | B2 |
D823478 | Park | Jul 2018 | S |
10034813 | Silver | Jul 2018 | B1 |
D826418 | Lad | Aug 2018 | S |
D837395 | Gan | Jan 2019 | S |
D838378 | Cao | Jan 2019 | S |
D840547 | Harle et al. | Feb 2019 | S |
10201470 | Griner | Feb 2019 | B2 |
D842489 | Spewock et al. | Mar 2019 | S |
D842491 | Fleming et al. | Mar 2019 | S |
D843656 | Zhang et al. | Mar 2019 | S |
D844896 | Levi et al. | Apr 2019 | S |
D847362 | Tang | Apr 2019 | S |
D847364 | Lee et al. | Apr 2019 | S |
10252051 | Nichols | Apr 2019 | B2 |
10276844 | Wackwitz et al. | Apr 2019 | B2 |
D847990 | Kimball | May 2019 | S |
10314762 | Marton et al. | Jun 2019 | B1 |
10335345 | Choe | Jul 2019 | B2 |
10357425 | Wersland et al. | Jul 2019 | B2 |
D855822 | Marton et al. | Aug 2019 | S |
D858432 | Altenburger | Sep 2019 | S |
D862382 | Altenburger | Oct 2019 | S |
D866790 | Lee et al. | Nov 2019 | S |
D867279 | Altenburger | Nov 2019 | S |
10557490 | Wersland et al. | Feb 2020 | B2 |
D877351 | Wersland et al. | Mar 2020 | S |
D880419 | Hernandez et al. | Apr 2020 | S |
D880714 | Wersland et al. | Apr 2020 | S |
D880715 | Wersland et al. | Apr 2020 | S |
D880716 | Wersland et al. | Apr 2020 | S |
D884205 | Zhuang | May 2020 | S |
10702448 | Wersland et al. | Jul 2020 | B2 |
D893738 | Zhuang | Aug 2020 | S |
10758027 | Skidmore et al. | Sep 2020 | B2 |
10857064 | Wersland et al. | Dec 2020 | B2 |
10918565 | Wersland et al. | Feb 2021 | B2 |
10945915 | Wersland et al. | Mar 2021 | B2 |
10959908 | Lee et al. | Mar 2021 | B2 |
10959911 | Wersland et al. | Mar 2021 | B2 |
D919560 | Taniguchi et al. | May 2021 | S |
10993874 | Marton et al. | May 2021 | B1 |
11160723 | Wersland et al. | Nov 2021 | B2 |
11478400 | Marton | Oct 2022 | B1 |
11478606 | English et al. | Oct 2022 | B1 |
20010016697 | Gorsen | Aug 2001 | A1 |
20010027280 | Huang | Oct 2001 | A1 |
20020082532 | Tucek et al. | Jun 2002 | A1 |
20020115947 | Young | Aug 2002 | A1 |
20020177795 | Frye | Nov 2002 | A1 |
20020183668 | Huang | Dec 2002 | A1 |
20020188233 | Denyes | Dec 2002 | A1 |
20030009116 | Luettgen et al. | Jan 2003 | A1 |
20030014079 | Tucek | Jan 2003 | A1 |
20030028134 | Lev et al. | Feb 2003 | A1 |
20030094356 | Waldron | May 2003 | A1 |
20030144615 | Lin | Jul 2003 | A1 |
20030195443 | Miller | Oct 2003 | A1 |
20040176710 | Kennedy et al. | Sep 2004 | A1 |
20050075591 | Hafemann | Apr 2005 | A1 |
20050109137 | Hartmann | May 2005 | A1 |
20050113870 | Miller | May 2005 | A1 |
20050126018 | Haas | Jun 2005 | A1 |
20050131461 | Tucek et al. | Jun 2005 | A1 |
20050203445 | Tsai | Sep 2005 | A1 |
20050235988 | Hansen et al. | Oct 2005 | A1 |
20050252011 | Neumeier | Nov 2005 | A1 |
20060025710 | Schulz et al. | Feb 2006 | A1 |
20060047315 | Colloca et al. | Mar 2006 | A1 |
20060074455 | Strandberg | Apr 2006 | A1 |
20060116614 | Jones et al. | Jun 2006 | A1 |
20060118841 | Eliason et al. | Jun 2006 | A1 |
20060123941 | Wadge | Jun 2006 | A1 |
20060192527 | Kageler et al. | Aug 2006 | A1 |
20060211961 | Meyer et al. | Sep 2006 | A1 |
20060272664 | O'Dwyer | Dec 2006 | A1 |
20070129220 | Bardha | Jun 2007 | A1 |
20070144310 | Pozgay et al. | Jun 2007 | A1 |
20070150004 | Colloca et al. | Jun 2007 | A1 |
20070173886 | Rousso et al. | Jul 2007 | A1 |
20070179414 | Imboden et al. | Aug 2007 | A1 |
20070270727 | Khorassani Zadeh | Nov 2007 | A1 |
20070282228 | Einav et al. | Dec 2007 | A1 |
20080077061 | Dehli | Mar 2008 | A1 |
20080097260 | Tsukada et al. | Apr 2008 | A1 |
20080103419 | Adamson | May 2008 | A1 |
20080146980 | Rousso et al. | Jun 2008 | A1 |
20080167588 | Chen | Jul 2008 | A1 |
20080169715 | Mills et al. | Jul 2008 | A1 |
20080177207 | Liao | Jul 2008 | A1 |
20080185888 | Beall et al. | Aug 2008 | A1 |
20080200849 | Hollington et al. | Aug 2008 | A1 |
20080243041 | Brenner et al. | Oct 2008 | A1 |
20080306417 | Imboden et al. | Dec 2008 | A1 |
20080312568 | Chen | Dec 2008 | A1 |
20080314610 | Meixner | Dec 2008 | A1 |
20090112134 | Avni | Apr 2009 | A1 |
20090188119 | Oberheim | Jul 2009 | A1 |
20090270777 | Wu et al. | Oct 2009 | A1 |
20090309313 | Knorr et al. | Dec 2009 | A1 |
20090326540 | Estes | Dec 2009 | A1 |
20100100119 | Herndon | Apr 2010 | A1 |
20100137907 | Tsai | Jun 2010 | A1 |
20100145242 | Tsai | Jun 2010 | A1 |
20100160841 | Wu | Jun 2010 | A1 |
20100162579 | Naughton et al. | Jul 2010 | A1 |
20100176919 | Myers et al. | Jul 2010 | A1 |
20100210194 | Thomaschewski et al. | Aug 2010 | A1 |
20100274162 | Evans | Oct 2010 | A1 |
20100286569 | Nagano | Nov 2010 | A1 |
20100298863 | Hindinger et al. | Nov 2010 | A1 |
20110037431 | Mackle | Feb 2011 | A1 |
20110055720 | Potter et al. | Mar 2011 | A1 |
20110118637 | Lev et al. | May 2011 | A1 |
20110201979 | Voss et al. | Aug 2011 | A1 |
20110224580 | Leathers et al. | Sep 2011 | A1 |
20110314677 | Meier et al. | Dec 2011 | A1 |
20120059294 | Schubert et al. | Mar 2012 | A1 |
20120065556 | Smith et al. | Mar 2012 | A1 |
20120078071 | Bohm et al. | Mar 2012 | A1 |
20120124758 | Sabisch et al. | May 2012 | A1 |
20120161706 | Zhou | Jun 2012 | A1 |
20120197357 | Dewey et al. | Aug 2012 | A1 |
20120232445 | Lev et al. | Sep 2012 | A1 |
20120238922 | Stemple et al. | Sep 2012 | A1 |
20120253245 | Stanbridge | Oct 2012 | A1 |
20130014968 | Kehoe et al. | Jan 2013 | A1 |
20130030506 | Bartolone et al. | Jan 2013 | A1 |
20130046212 | Nichols | Feb 2013 | A1 |
20130052871 | Eklind | Feb 2013 | A1 |
20130085421 | Gillespie et al. | Apr 2013 | A1 |
20130116503 | Mertens et al. | May 2013 | A1 |
20130133210 | Weir et al. | May 2013 | A1 |
20130138023 | Lerro | May 2013 | A1 |
20130218058 | Ceoldo et al. | Aug 2013 | A1 |
20130237751 | Alexander | Sep 2013 | A1 |
20130241470 | Kim | Sep 2013 | A1 |
20130261516 | Cilea et al. | Oct 2013 | A1 |
20130261517 | Rodgers | Oct 2013 | A1 |
20130271067 | Yu et al. | Oct 2013 | A1 |
20130281897 | Hoffmann et al. | Oct 2013 | A1 |
20130304642 | Campos | Nov 2013 | A1 |
20140024982 | Doyle | Jan 2014 | A1 |
20140031866 | Fuhr et al. | Jan 2014 | A1 |
20140097793 | Wurtz et al. | Apr 2014 | A1 |
20140101872 | Utsch et al. | Apr 2014 | A1 |
20140163443 | Young et al. | Jun 2014 | A1 |
20140180331 | Turner | Jun 2014 | A1 |
20140190023 | Vitantonio et al. | Jul 2014 | A1 |
20140194900 | Sedic | Jul 2014 | A1 |
20140200495 | Jones | Jul 2014 | A1 |
20140207032 | Dematio et al. | Jul 2014 | A1 |
20140209594 | Besner | Jul 2014 | A1 |
20140221887 | Wu | Aug 2014 | A1 |
20140288473 | Matsushita | Sep 2014 | A1 |
20140305747 | Kumar et al. | Oct 2014 | A1 |
20140310900 | Curry et al. | Oct 2014 | A1 |
20140316313 | Mayer et al. | Oct 2014 | A1 |
20150005682 | Danby | Jan 2015 | A1 |
20150042254 | Kato | Feb 2015 | A1 |
20150082562 | Kamada | Mar 2015 | A1 |
20150098184 | Tsai et al. | Apr 2015 | A1 |
20150119771 | Roberts | Apr 2015 | A1 |
20150133833 | Bradley et al. | May 2015 | A1 |
20150145297 | Lee | May 2015 | A1 |
20150148592 | Kanbar et al. | May 2015 | A1 |
20150157528 | Le et al. | Jun 2015 | A1 |
20150176674 | Khan et al. | Jun 2015 | A1 |
20150216719 | DeBenedictis et al. | Aug 2015 | A1 |
20150257964 | Ajiki | Sep 2015 | A1 |
20150305969 | Giraud et al. | Oct 2015 | A1 |
20150328081 | Goldenberg et al. | Nov 2015 | A1 |
20150375315 | Ukai et al. | Dec 2015 | A1 |
20160000642 | Zipper | Jan 2016 | A1 |
20160017905 | Cascolan et al. | Jan 2016 | A1 |
20160030279 | Driscoll et al. | Feb 2016 | A1 |
20160045661 | Gray et al. | Feb 2016 | A1 |
20160112841 | Holland | Apr 2016 | A1 |
20160113840 | Crunick et al. | Apr 2016 | A1 |
20160113841 | Godfrey et al. | Apr 2016 | A1 |
20160127129 | Chee et al. | May 2016 | A1 |
20160129186 | Douglas et al. | May 2016 | A1 |
20160136037 | Cai | May 2016 | A1 |
20160136040 | Li | May 2016 | A1 |
20160166464 | Douglas et al. | Jun 2016 | A1 |
20160170996 | Frank et al. | Jun 2016 | A1 |
20160192814 | Kang et al. | Jul 2016 | A1 |
20160206502 | Køltzow | Jul 2016 | A1 |
20160243359 | Sharma | Aug 2016 | A1 |
20160263732 | Lourenco et al. | Sep 2016 | A1 |
20160269486 | Gupta et al. | Sep 2016 | A1 |
20160310353 | Barasch | Oct 2016 | A1 |
20160311091 | Wang | Oct 2016 | A1 |
20160324717 | Burton | Nov 2016 | A1 |
20160338901 | Cohen | Nov 2016 | A1 |
20160346163 | Konik et al. | Dec 2016 | A1 |
20160367425 | Wersland | Dec 2016 | A1 |
20170027798 | Wersland | Feb 2017 | A1 |
20170042754 | Fowers et al. | Feb 2017 | A1 |
20170049278 | Thomassen | Feb 2017 | A1 |
20170069191 | Erkkila | Mar 2017 | A1 |
20170119623 | Attarian | May 2017 | A1 |
20170128320 | Chen | May 2017 | A1 |
20170156974 | Griner | Jun 2017 | A1 |
20170156975 | Mills | Jun 2017 | A1 |
20170189227 | Brunson et al. | Jul 2017 | A1 |
20170216136 | Gordon | Aug 2017 | A1 |
20170233063 | Zhao et al. | Aug 2017 | A1 |
20170246074 | Wu | Aug 2017 | A1 |
20170304144 | Tucker | Oct 2017 | A1 |
20170304145 | Pepe | Oct 2017 | A1 |
20170312161 | Johnson et al. | Nov 2017 | A1 |
20170360641 | Nakata et al. | Dec 2017 | A1 |
20180008512 | Goldstein | Jan 2018 | A1 |
20180050440 | Chen | Feb 2018 | A1 |
20180078449 | Callow | Mar 2018 | A1 |
20180133101 | Inada | May 2018 | A1 |
20180140100 | Cribbs | May 2018 | A1 |
20180140502 | Shahoian et al. | May 2018 | A1 |
20180141188 | Lai | May 2018 | A1 |
20180154141 | Ahn | Jun 2018 | A1 |
20180185234 | Ishiguro et al. | Jul 2018 | A1 |
20180200141 | Wersland et al. | Jul 2018 | A1 |
20180236572 | Ukai | Aug 2018 | A1 |
20180243158 | Loghmani et al. | Aug 2018 | A1 |
20180263845 | Wersland et al. | Sep 2018 | A1 |
20180279843 | Paul et al. | Oct 2018 | A1 |
20180288160 | Paul et al. | Oct 2018 | A1 |
20180296433 | Danby et al. | Oct 2018 | A1 |
20180315499 | Appelbaum et al. | Nov 2018 | A1 |
20180315504 | Inada et al. | Nov 2018 | A1 |
20190000709 | Sone et al. | Jan 2019 | A1 |
20190038229 | Perraut et al. | Feb 2019 | A1 |
20190066833 | Wicki | Feb 2019 | A1 |
20190110945 | Kawagoe et al. | Apr 2019 | A1 |
20190175434 | Zhang | Jun 2019 | A1 |
20190209424 | Wersland et al. | Jul 2019 | A1 |
20190216677 | Paul | Jul 2019 | A1 |
20190232478 | Zawisza et al. | Aug 2019 | A1 |
20190254921 | Marton et al. | Aug 2019 | A1 |
20190254922 | Marton et al. | Aug 2019 | A1 |
20190314239 | Ci | Oct 2019 | A1 |
20190337140 | Shanklin | Nov 2019 | A1 |
20190350793 | Wersland et al. | Nov 2019 | A1 |
20190381271 | Jo | Dec 2019 | A1 |
20200000237 | Wu | Jan 2020 | A1 |
20200009010 | Park et al. | Jan 2020 | A1 |
20200016027 | Kim et al. | Jan 2020 | A1 |
20200035237 | Kim et al. | Jan 2020 | A1 |
20200069510 | Wersland et al. | Mar 2020 | A1 |
20200085675 | Lee et al. | Mar 2020 | A1 |
20200090175 | Davis et al. | Mar 2020 | A1 |
20200179210 | Barragan Gomez | Jun 2020 | A1 |
20200179215 | Lerner | Jun 2020 | A1 |
20200230012 | Fuhr | Jul 2020 | A1 |
20200241683 | Le et al. | Jul 2020 | A1 |
20200261306 | Pepe | Aug 2020 | A1 |
20200261307 | Wersland et al. | Aug 2020 | A1 |
20200268594 | Pepe | Aug 2020 | A1 |
20200294423 | Blain et al. | Sep 2020 | A1 |
20200352821 | Wersland et al. | Nov 2020 | A1 |
20200390644 | Yang | Dec 2020 | A1 |
20200397651 | Park et al. | Dec 2020 | A1 |
20200405570 | Kodama | Dec 2020 | A1 |
20210000683 | Cheng | Jan 2021 | A1 |
20210022951 | Hu | Jan 2021 | A1 |
20210022955 | Wersland et al. | Jan 2021 | A1 |
20210059898 | Wersland et al. | Mar 2021 | A1 |
20210085555 | Davis et al. | Mar 2021 | A1 |
20210128402 | Dai et al. | May 2021 | A1 |
20210330539 | Faussett | Oct 2021 | A1 |
20220000781 | Leneweit et al. | Jan 2022 | A9 |
20220007810 | Paspatis et al. | Jan 2022 | A1 |
20220054350 | Merino et al. | Feb 2022 | A1 |
20220087433 | Mao et al. | Mar 2022 | A1 |
20220241135 | Wang | Aug 2022 | A1 |
20230001131 | English et al. | Jan 2023 | A1 |
Number | Date | Country |
---|---|---|
510048 | Jan 2012 | AT |
2019204770 | Oct 2019 | AU |
86101310 | Sep 1986 | CN |
1432452 | Jul 2003 | CN |
2788807 | Jun 2006 | CN |
201239336 | May 2009 | CN |
201239338 | May 2009 | CN |
201333160 | Oct 2009 | CN |
201524220 | Jul 2010 | CN |
101888050 | Nov 2010 | CN |
201743890 | Feb 2011 | CN |
201847899 | Jun 2011 | CN |
301664182 | Sep 2011 | CN |
202161539 | Mar 2012 | CN |
202637439 | Jan 2013 | CN |
103648320 | Mar 2014 | CN |
203598194 | May 2014 | CN |
104352341 | Feb 2015 | CN |
303250924 | Jun 2015 | CN |
303250929 | Jun 2015 | CN |
205163583 | Apr 2016 | CN |
104352341 | Jul 2016 | CN |
205459750 | Aug 2016 | CN |
205494357 | Aug 2016 | CN |
205598186 | Sep 2016 | CN |
106074129 | Nov 2016 | CN |
106236528 | Dec 2016 | CN |
206081000 | Apr 2017 | CN |
106859949 | Jun 2017 | CN |
304561844 | Mar 2018 | CN |
207286298 | May 2018 | CN |
108543126 | Sep 2018 | CN |
207855923 | Sep 2018 | CN |
109009978 | Dec 2018 | CN |
109259995 | Jan 2019 | CN |
208405314 | Jan 2019 | CN |
208448086 | Feb 2019 | CN |
109528473 | Mar 2019 | CN |
209154392 | Jul 2019 | CN |
110868983 | Mar 2020 | CN |
106618998 | Aug 2020 | CN |
111616938 | Sep 2020 | CN |
111973419 | Nov 2020 | CN |
113143721 | Jul 2021 | CN |
113509366 | Oct 2021 | CN |
3633888 | Apr 1988 | DE |
19905199 | Jul 2000 | DE |
102015102112 | Aug 2015 | DE |
202015005257 | Oct 2016 | DE |
0436719 | May 1994 | EP |
1728494 | Dec 2006 | EP |
2080500 | Jul 2009 | EP |
2328255 | Jun 2011 | EP |
1728494 | Jan 2013 | EP |
2066081 | Jul 1981 | GB |
2262236 | Jun 1993 | GB |
S5230553 | Mar 1977 | JP |
S5428491 | Mar 1979 | JP |
H 0219157 | Jan 1990 | JP |
H03218763 | Sep 1991 | JP |
H048128 | Feb 1992 | JP |
H 0447440 | Feb 1992 | JP |
H 0447440 | Apr 1992 | JP |
H 0751393 | Feb 1995 | JP |
2000189525 | Jul 2000 | JP |
003077837 | Jun 2001 | JP |
2002282322 | Oct 2002 | JP |
2003077837 | Mar 2003 | JP |
2005204777 | Aug 2005 | JP |
2006034941 | Feb 2006 | JP |
2006212228 | Aug 2006 | JP |
2008510588 | Apr 2008 | JP |
2008289616 | Dec 2008 | JP |
2010534110 | Nov 2010 | JP |
2011502369 | Jan 2011 | JP |
5129032 | Jan 2013 | JP |
2013119018 | Jun 2013 | JP |
2014511240 | May 2014 | JP |
2015035844 | Feb 2015 | JP |
2015104422 | Jun 2015 | JP |
2018518347 | Jul 2018 | JP |
200313149 | May 2003 | KR |
200435552 | Jan 2007 | KR |
100752432 | Aug 2007 | KR |
20090119424 | Nov 2009 | KR |
101123926 | Apr 2012 | KR |
101162978 | Jul 2012 | KR |
101406275 | Jun 2014 | KR |
20170106550 | Sep 2017 | KR |
20170108550 | Sep 2017 | KR |
20180031683 | Mar 2018 | KR |
20200051098 | May 2020 | KR |
2170567 | Jul 2001 | RU |
I359657 | Mar 2012 | TW |
201440753 | Nov 2014 | TW |
WO-0119316 | Mar 2001 | WO |
WO 2009014727 | Jan 2009 | WO |
WO-2009102279 | Aug 2009 | WO |
WO-2011159317 | Dec 2011 | WO |
WO 2013114084 | Aug 2013 | WO |
WO-2013145346 | Oct 2013 | WO |
WO 2014118596 | Aug 2014 | WO |
WO 2015038005 | Mar 2015 | WO |
WO-2018012105 | Jan 2018 | WO |
WO-2019186225 | Oct 2019 | WO |
WO-2021050861 | Mar 2021 | WO |
WO-2023172676 | Sep 2023 | WO |
Entry |
---|
TheraGun device in YouTube video “TheraGun: What it Does,” https://www.youtubecom/watch?v=FB_JTZnD7vs; Aug. 24, 2016 (upload date). |
TheraGun device in Archiveorg webpage, https://web.archiveorg/web/20151218063848/http://www.lheraguncom/#intro-1, Dec. 18, 2015 {archive date). |
TheraGun G1 device in YouTube video “Theragun G1: Product Overview,” https://wwwyoutubecom/watch?v=m9ilhfMGIZ8, Apr. 18, 2017 (upload date). |
TheraGun G2Pro device in YouTube video “The Theragun G2PRO: Revolutionary Percussive Therapy,” https://www youtubecom/watch?v=2p9R6VA798o, Oct. 10, 2017 (upload date). |
International Search Report and Written Opinion issued in PCT/US2021/029903 dated Jul. 2, 2021. |
PCT/US2016/038326 International Search Report & Written Opinion dated Sep. 1, 2016. |
PCT/US2018/022426 International Search Report & Written Opinion dated May 31, 2018. |
AU 2016284030 Examination Report dated May 7, 2018. |
JP2018-517683 Office Action. |
CA 2990178 Office Action. |
WORX Trans4mer “Safety and Operating Manual Original Instructions” for 12V Li-Ion Multi-purpose saw, WX540, NX540.3, WX540.9, 2013. |
Rachel [no family name indicated], “Jigsaw Massager”, Apr. 18, 2010 (https://web.archiveorg/web/20100418041422/ http://www.instructables.com/id/Jigsaw-Massager/). |
Rockwell Trans4mer Operating Manual for Multi-purpose saw, Model RK2516/RK2516K, 2011. |
PCT/US2020/031936 International Search Report & Written Opinion dated Sep. 11, 2020. |
Intemational Search Report and Written Opinion issued in PCT/US20/50385 dated Dec. 3, 2020. |
Notice of First Examination Opinion directed to Chinese Patent Application No. 202180041926.3, dated Jul. 7, 2023; 16 pages. |
Amazon: “OIVO Xbox One Controller Charger Dual Charging Station Updated Strap, Remote Charger Dock-2 Rechargeable Battery Packs Included,” OIVO, Sep. 6, 2018, Especially annotated figures, Retrieved from Entire Document, 11 Pages. |
Amazon: “PowerA Joy Con & Pro Controller Charging Dock Nintendo Switch,” PowerA, Oct. 31, 2017, Especially annotated figures, Retrieved from Entire Document, 10 Pages. |
Amazon: “Theragun G3PRO Percussive Therapy Device, White, Handheld Deep Muscle, Treatment Massager & Muscle Stimulator for Pain Relief, Recovery, Enhance Performance & Energize the Body,” Feb. 13, 2019, Shown on pp. 1, 2 Pages, Retrieved from URL: https://www.amazon.com/dp/B07MJ2MCT3/ref=nav_timeline_asin?_encoding=UTF8&psc=1. |
Anthony Katz, “The RAPTOR: Helps Patients and Saves Your Most Valuable Tool . . . Your Hands,” DC Aligned:MeyerDC, Dec. 9, 2015, available at: http://news.meyerdc.com/community/vendor-spotlight/the-raptor-helps-patients-saves-your-most-valuable-tool-your-hands/ (last visited Feb. 15, 2023); 5 pages. |
Bardwell D., “Wahl's Massage Products—Meant for Life's Big Pains,” DougBardwell.com, Apr. 6, 2016, 7 Pages, [Retrieved on Jun. 3, 2021] Retrieved from URL: https://dougbardwell.com/db/2016/04/06/wahls-massage-products-meant-for-lifes-big-pains/. |
Collins D., “External Rotor Motor Basics: Design and Applications,” Jun. 6, 2018, 03 Pages. |
Collins D., “FAQ: What are Hall Effect Sensors and What is Theirs Role in DC Motors?,” Jan. 11, 2017, 03 Pages. |
Defendant's Initial Invalidity Contentions, Therabody, Inc. v. Tzumi Electronics LLC et al., Case No. SDNY-1-21-cv-07803 (PGG)(RWL), dated Aug. 17, 2022; 16 pages. |
Description of Therabody GI Device, available at: https://www.therabody.com/us/en-us/faq/thearagun-devices/faq-devices-1.html?fdid=faq&csortb1=sortOrder&csortd1=1 (last visited Feb. 15, 2023). |
Digi-Key's North American Editors: “How to Power and Control Brushless DC Motors,” Dec. 7, 2016, 09 Pages. |
Extended European Search Report for European Application No. 16815104.1, dated Jan. 23, 2019, 08 Pages. |
Extended European Search Report for European Application No. 18832213.5, dated Jul. 21, 2021, 11 Pages. |
Extended European Search Report for European Application No. 18832923.9, dated Apr. 23, 2021, 7 Pages. |
Extended European Search Report for European Application No. 20720323.3, dated Sep. 9, 2021, 10 Pages. |
Extended European Search Report for European Application No. 20802710.2, dated May 10, 2022, 9 Pages. |
Extended European Search Report for European Application No. 20802804.3, dated Apr. 28, 2022, 8 Pages. |
Extended European Search Report for European Application No. 21178300.6, dated Oct. 19, 2021, 9 Pages. |
Extended European Search Report for European Application No. 21178311.3, dated Sep. 23, 2021, 5 Pages. |
Holly Riddle, “Theragun vs. Hyperice vs, Hydragun: Massage Gun Showdown [Buyer's Guide],” ChatterSource: Health & Wellness, Mar. 9, 2021, available at: https://www.chattersource.com/article/massage-gun/ (last visited Feb. 17, 2023); 14 pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2016/038326, dated Jan. 4, 2018, 8 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2018/022426, dated Sep. 26, 2019, 9 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2018/039599, dated Jan. 23, 2020, 8 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2018/040795, dated Jan. 23, 2020, 7 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2019/067624, dated Jul. 8, 2021, 11 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2020/017645, dated Aug. 26, 2021, 11 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2020/031339, dated Nov. 18, 2021,11 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2020/031936, dated Nov. 18, 2021, 14 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2020/050385, dated Mar. 24, 2022, 12 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2020/050399, dated Jan. 13, 2022, 6 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2020/054773, dated Apr. 21, 2022, 8 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2020/054842, dated Apr. 21, 2022, 7 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2020/063426, dated Jun. 16, 2022, 06 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2021/022500, dated Oct. 6, 2022, 6 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2021/029900, dated Nov. 10, 2022, 9 Pages. |
International Preliminary Report on Patentability for International Application No. PCT/US2021/029903, dated Nov. 10, 2022, 7 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2018/039599, dated Sep. 24, 2018, 9 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2018/040795, dated Sep. 24, 2018, 8 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2019/067624, dated Feb. 3, 2020, 13 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2020/017645, dated May 20, 2020, 13 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2020/031339, dated Jun. 10, 2020, 12 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2020/031347, dated Aug. 3, 2020, 9 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2020/050399, dated Feb. 4, 2021, 11 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2020/054773, dated Jan. 12, 2021, 9 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2020/054842, dated Jan. 11, 2021, 8 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2020/063426, dated Feb. 26, 2021, 09 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2021/022500, dated Apr. 20, 2021, 7 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2021/029900, dated Oct. 6, 2021, 12 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2022/028309, dated Sep. 8, 2022, 10 Pages. |
International Search Report and Written Opinion for International Application No. PCT/US2022/076238, dated Jan. 23, 2023, 12 Pages. |
Machine translation from Espacenet of written description and claims for CN106074129A, 9 pages (2016). |
Machine translation from Espacenet of written description and claims for CN111616938A, 5 pages (2020). |
Machine translation from Espacenet of written description and claims for CN111973419A, 7 pages (2020). |
Machine Translation of Written Description and Claims for WO2013145346A1 (Year: 2013). |
Massage Expert: “Nursal Deep Percussion Massager Review—6 Interchangeable Nodes,” Jan. 4, 2021, 6 Pages, [Retrieved on Jun. 3, 2021] Retrieved from URL: https://www.massagexpert.net/nursal-deep-percussion-massager-review/. |
McFarland M., “Segway Was Supposed to Change the World, Two Decades Later, It Just Might,” CNN Wire Service, Oct. 30, 2018, 7 Pages. |
Partial Supplementary European Search Report for European Application No. 18832213.5, dated Apr. 20, 2021, 12 Pages. |
Supplementary European Search Report for European Application No. 19904459.5, dated Apr. 15, 2021, 04 Pages. |
testberichte.de: “Naipo Handheld Percussion Massager with Heating (MGPC 5000),” amazon.de, 7 Pages, [Retrieved on Jun. 3, 2021] Retrieved from URL: https://www.testberichte.de/p/naipo-tests/handheld-percussion-massager-with-heating-mgpc-5000-testbericht.html, See also a YouTube Review of this Device dated May 21, 2018 at https://www.youtube.com/watch?v=bi_QCJA3D9k. |
Visual Description of Hyper Ice, Inc. Raptor Device, “Osteopatia Haidy Ortale—Raptor Massage,” available at: https://www.youtube.com/watch?v=plyW8FBowVs (last visited Feb. 15, 2023); 1 page. |
Visual Description of Hyper Ice, Inc. Raptor Device, “Raptor Solutions 1.3 Prone,” available at: https://www.youtube.com/watch?v=6i1tRqdwPU8&t=156s (last visited Feb. 15, 2023); 1 page. |
WORX: “Safety and Operating Manual Original Instructions,” for 12V Li-Ion Multipurpose saw, WX540, WX540.3, WX540.9, Trans4mer, 2013, 16 Pages. |
Youtube: “Unboxing: Joy-Con & Pro Controller Charging Dock for Nintendo Switch,” Crusherbad64, Especially demonstration 8:30-8:55, (This reference is Being Used to Show Greater Details of Product not Clearly Disclosed in ‘PowerA’), Feb. 26, 2018, Retrieved from entire document, 1 Page. |
Number | Date | Country | |
---|---|---|---|
20230248609 A1 | Aug 2023 | US |
Number | Date | Country | |
---|---|---|---|
62844424 | May 2019 | US | |
62899098 | Sep 2019 | US | |
62912392 | Oct 2019 | US | |
62785151 | Dec 2018 | US | |
63133951 | Jan 2021 | US | |
63017472 | Apr 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17244278 | Apr 2021 | US |
Child | 18162499 | US | |
Parent | 17739630 | May 2022 | US |
Child | 17244278 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17018099 | Sep 2020 | US |
Child | 17244278 | US | |
Parent | 16869402 | May 2020 | US |
Child | 17018099 | US | |
Parent | 16796143 | Feb 2020 | US |
Child | 16869402 | US | |
Parent | 16675772 | Nov 2019 | US |
Child | 16869402 | US | |
Parent | 17244239 | Apr 2021 | US |
Child | 17739630 | US | |
Parent | 17018099 | Sep 2020 | US |
Child | 17244239 | US | |
Parent | 17705300 | Mar 2022 | US |
Child | 17739630 | US |